Hamaï A - Search Results

1

mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions.

Cosialls E, Pacreau E, Duruel C, Ceccacci S, Elhage R, Desterke C, Roger K, Guerrera C, Ducloux R, Souquere S, Pierron G, Nemazanyy I, Kelly M, Dalmas E, Chang Y, Goffin V, Mehrpour M, Hamaï A. Cosialls E, et al. Among authors: hamai a. Cell Death Dis. 2023 Nov 15;14(11):744. doi: 10.1038/s41419-023-06262-5. Cell Death Dis. 2023. PMID: 37968262 Free PMC article.

2

Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.

Hamaï A, Duperrier-Amouriaux K, Pignon P, Raimbaud I, Memeo L, Colarossi C, Canzonieri V, Perin T, Classe JM, Campone M, Jézéquel P, Campion L, Ayyoub M, Valmori D. Hamaï A, et al. PLoS One. 2011;6(6):e21129. doi: 10.1371/journal.pone.0021129. Epub 2011 Jun 17. PLoS One. 2011. PMID: 21747904 Free PMC article.

3

Two distinct chondroitin sulfate ABC lyases. An endoeliminase yielding tetrasaccharides and an exoeliminase preferentially acting on oligosaccharides.

Hamai A, Hashimoto N, Mochizuki H, Kato F, Makiguchi Y, Horie K, Suzuki S. Hamai A, et al. J Biol Chem. 1997 Apr 4;272(14):9123-30. doi: 10.1074/jbc.272.14.9123. J Biol Chem. 1997. PMID: 9083041 Free article.

4

Human T(H)17 immune cells specific for the tumor antigen MAGE-A3 convert to IFN-γ-secreting cells as they differentiate into effector T cells in vivo.

Hamaï A, Pignon P, Raimbaud I, Duperrier-Amouriaux K, Senellart H, Hiret S, Douillard JY, Bennouna J, Ayyoub M, Valmori D. Hamaï A, et al. Cancer Res. 2012 Mar 1;72(5):1059-63. doi: 10.1158/0008-5472.CAN-11-3432. Epub 2012 Jan 17. Cancer Res. 2012. PMID: 22253231

5

New targets for acetylation in autophagy.

Hamaï A, Codogno P. Hamaï A, et al. Sci Signal. 2012 Jul 3;5(231):pe29. doi: 10.1126/scisignal.2003187. Sci Signal. 2012. PMID: 22763338

6

Expression of MAGE-A antigens is frequent in triple-negative breast cancers but does not correlate with that of basal-like markers.

Hamaï A, Memeo L, Colarossi C, Canzonieri V, Perin T, Ayyoub M, Valmori D. Hamaï A, et al. Ann Oncol. 2011 Apr;22(4):986-987. doi: 10.1093/annonc/mdr038. Epub 2011 Mar 1. Ann Oncol. 2011. PMID: 21363876 Free article. No abstract available.

7

Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.

Meslin F, Hamaï A, Gao P, Jalil A, Cahuzac N, Chouaib S, Mehrpour M. Meslin F, et al. Among authors: hamai a. Cancer Res. 2007 Nov 15;67(22):10910-9. doi: 10.1158/0008-5472.CAN-07-0512. Cancer Res. 2007. PMID: 18006836

8

Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance.

Yue W, Hamaï A, Tonelli G, Bauvy C, Nicolas V, Tharinger H, Codogno P, Mehrpour M. Yue W, et al. Among authors: hamai a. Autophagy. 2013 May;9(5):714-29. doi: 10.4161/auto.23997. Epub 2013 Mar 21. Autophagy. 2013. PMID: 23519090 Free PMC article.

9

Autophagy regulation and its role in cancer.

Lorin S, Hamaï A, Mehrpour M, Codogno P. Lorin S, et al. Among authors: hamai a. Semin Cancer Biol. 2013 Oct;23(5):361-79. doi: 10.1016/j.semcancer.2013.06.007. Epub 2013 Jun 27. Semin Cancer Biol. 2013. PMID: 23811268 Review.

10

Autophagy: A Druggable Process.

Morel E, Mehrpour M, Botti J, Dupont N, Hamaï A, Nascimbeni AC, Codogno P. Morel E, et al. Among authors: hamai a. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:375-398. doi: 10.1146/annurev-pharmtox-010716-104936. Annu Rev Pharmacol Toxicol. 2017. PMID: 28061686 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters